drugset / Trial / NCT03328507

A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects

NCT03328507

Phase 2 Completed 121 enrolled Braintree Laboratories
Non-randomizedSequentialOpen-labelTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of BLI4900 as a bowel preparation prior to colonoscopy in adult patients.

Timeline

Start
2017-11-09
Primary completion
2019-11-12
Completion
2019-11-12

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI4900 Unknown
Comparator polyethylene glycol Other / unclassified

Indications

No indication recorded.